While timelines differ from person to person, the overall trend across threads points to more noticeable results with consistent use over a longer period
AlyAM, Al-Alousi L, Salem HA
Another study suggested that combined QE and simvastatin attenuated hepatic fibrosis in rats by lowering serum levels of GOT, GPT, ALP, decreasing hepatic mRNA levels of sphingosine kinases type 1 (SphK1) and NLRP3 and elevating total antioxidant capacity, glutathione and Nrf2 expression levels, suggesting that targeting the SphK1/NLRP3 pathway could be a prospective therapeutic strategy against liver fibrosis (Salama et al., 2024)
These neuroprotective properties have significant implications for developing treatments for neurodegenerative diseases, protecting brain tissue following injury, and understanding how growth factor signaling contributes to neuronal resilience in aging and disease contexts